Mechanical strain and estrogen activate estrogen receptor alpha in bone cells

J Bone Miner Res. 2001 Jun;16(6):1045-55. doi: 10.1359/jbmr.2001.16.6.1045.

Abstract

Bone cells' early responses to estrogen and mechanical strain were investigated in the ROS 17/2.8 cell line. Immunoblotting with antiphosphorylated estrogen receptor a (ER-alpha) antibody showed that when these cells were exposed for 10 minutes to estrogen (10(-8) M) or a single period of cyclic dynamic strain (peak 3400 microepsilon, 1 Hz, 600 cycles), there was an increase in the intensity of a 66-kDa band, indicating phosphorylation of ser122 in the amino terminus of ER-alpha. Increased phosphorylation was detected within 5 minutes of exposure to estrogen and 5 minutes after the end of the period of strain. Estrogen and strain also activated the mitogen-activated protein kinase (MAPK) family member extracellular regulated kinase-1 (ERK-1). Increases in ERK activation coincided with increased ER-alpha phosphorylation. Activation of ERK-1 and the phosphorylation of ER-alpha, by both estrogen and strain, were prevented by the MAP kinase kinase (MEK) inhibitor U0126 and the protein kinase A (PKA) inhibitor (PKI). These data support previous suggestions that resident bone cells' early responses to strain and estrogen share a common pathway, which involves ER-alpha. This pathway also appears to involve PKA and ERK-mediated phosphorylation of ser122 within the amino terminus of ER-alpha. Reduced availability of this pathway when estrogen levels are reduced could explain diminished effectiveness of mechanically related control of bone architecture after the menopause.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bone and Bones / cytology
  • Bone and Bones / physiology*
  • Butadienes / pharmacology
  • Carrier Proteins / pharmacology
  • Cell Line
  • Cyclic AMP-Dependent Protein Kinases / antagonists & inhibitors
  • Cyclic AMP-Dependent Protein Kinases / drug effects
  • Cyclic AMP-Dependent Protein Kinases / metabolism
  • Enzyme Activation / drug effects
  • Enzyme Inhibitors / pharmacology
  • Estradiol / metabolism
  • Estradiol / pharmacology
  • Estrogen Receptor alpha
  • Estrogens / metabolism*
  • Estrogens / pharmacology
  • Humans
  • Immunoblotting
  • Intracellular Signaling Peptides and Proteins*
  • Mitogen-Activated Protein Kinase 1 / drug effects
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases / drug effects
  • Mitogen-Activated Protein Kinases / metabolism
  • Nitriles / pharmacology
  • Phosphorylation
  • Receptors, Estrogen / drug effects
  • Receptors, Estrogen / metabolism*
  • Serine / metabolism
  • Stress, Mechanical*

Substances

  • Butadienes
  • Carrier Proteins
  • Enzyme Inhibitors
  • Estrogen Receptor alpha
  • Estrogens
  • Intracellular Signaling Peptides and Proteins
  • Nitriles
  • Receptors, Estrogen
  • U 0126
  • protein kinase modulator
  • Serine
  • Estradiol
  • Cyclic AMP-Dependent Protein Kinases
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases